AdaptHealth Corp. AHCO
7.72 USD +0.37 (+5.03%)
At closeNov 11, 2026, 4:05 AM EST
7.79 +0.07 +0.91%
Pre-market · Nov 11, 4:05 AM ET
7.24 Day range 7.82
5.21 52-week range 13.43
- YTD
- -22.49%
- 1 year
- -17.87%
News
seekingalpha.com AdaptHealth Corp. (AHCO) Presents at 2026 UBS Global Healthcare Conference Transcript AdaptHealth Corp. ( AHCO ) 2026 UBS Global Healthcare Conference November 10, 2026 2:45 PM EST Company Participants Suzanne Foster - CEO & Director Conference Call Participants Kevin Caliendo - UBS…
benzinga.com Leerink Partners Maintains Outperform on AdaptHealth, Raises Price Target to $8 Leerink Partners analyst Whit Mayo maintains AdaptHealth (NASDAQ:AHCO) with a Outperform and raises the price target from $7 to $8.
defenseworld.net What AdaptHealth (AHCO) Said on Its Q3 Earnings Call AdaptHealth (NASDAQ: AHCO) reported third-quarter results that exceeded its revenue and adjusted EBITDA guidance, citing improving performance in its largest capitated contract, continued organic…
benzinga.com UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9 UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.
benzinga.com AdaptHealth Q3 2026 Earnings Call Transcript AdaptHealth (NASDAQ:AHCO) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com AdaptHealth Raises FY2026 Sales Guidance from $2.850B-$2.890B to $2.880B-$2.900B vs $2.955B Est AdaptHealth (NASDAQ:AHCO) raises FY2026 sales outlook from $2.850 billion-$2.890 billion to $2.880 billion-$2.900 billion vs $2.955 billion estimate.
benzinga.com AdaptHealth Q3 Sales $745.648M Miss $746.446M Estimate AdaptHealth (NASDAQ:AHCO) reported quarterly sales of $745.648 million which missed the analyst consensus estimate of $746.446 million by 0.11 percent. This is a 9.10 percent decrease over sales of…